Top 10 Pharma Companies in India

India is one of the world's major pharmaceutical manufacturing and supply centres, with companies serving both the domestic market and international markets. Indian pharmaceutical businesses operate across generic medicines, branded formulations, active pharmaceutical ingredients, specialty medicines, biosimilars, contract manufacturing and research.

For readers searching for the top 10 pharma companies in India, this article covers major Indian pharmaceutical companies based primarily on business scale and FY 2024–25 revenue, while also considering domestic presence, international operations, product portfolio and industry importance.

The ranking is editorial and not an official government ranking. Different rankings can produce different results depending on whether they measure total revenue, Indian pharmaceutical-market sales, market capitalisation, manufacturing capacity or another metric. The companies discussed here include Sun Pharmaceutical Industries, Dr. Reddy's Laboratories, Aurobindo Pharma, Cipla, Zydus Lifesciences, Lupin, Biocon, Glenmark Pharmaceuticals, Alkem Laboratories and Mankind Pharma.

Overview of the Top Pharma Companies in India

India's pharmaceutical industry includes companies of very different sizes and business models. Some have a strong domestic branded-generics business, while others generate a significant portion of their revenue from the United States and other international markets.

A FY 2024–25 comparison of leading pharmaceutical companies placed Sun Pharma at the top by revenue, followed by Dr. Reddy's Laboratories, Aurobindo Pharma, Cipla and Zydus Lifesciences. Lupin, Biocon, Glenmark Pharma, Alkem Laboratories and Mankind Pharma also ranked among the major companies in the sector.

Editorial Rank	Company	Major Business Areas	Key Strength
1	Sun Pharmaceutical Industries	Generics, specialty medicines, branded formulations	Scale and diversified global business
2	Dr. Reddy's Laboratories	Generics, APIs, biosimilars and innovative products	Strong international presence
3	Aurobindo Pharma	Generics, APIs and specialty pharmaceuticals	Large manufacturing and global reach
4	Cipla	Generics, respiratory and branded medicines	Strong Indian market presence
5	Zydus Lifesciences	Generics, specialty medicines, APIs and vaccines	Broad pharmaceutical portfolio
6	Lupin	Generics, specialty medicines and APIs	Strong US and Indian businesses
7	Biocon	Biologics, biosimilars and generics	Biopharmaceutical expertise
8	Glenmark Pharmaceuticals	Branded generics, specialty and innovative medicines	Focus on specialty and research
9	Alkem Laboratories	Branded generics, generics and specialty products	Strong domestic presence
10	Mankind Pharma	Branded generics and consumer healthcare	Strong Indian prescription and consumer brands

The ordering above should be viewed as an editorial ranking based primarily on overall business scale rather than a claim that one company's products are universally better than another's.

How the Ranking Was Prepared

There is no single official list of the "top 10 pharma companies in India." Therefore, the ranking uses a combination of factors.

Revenue and Business Scale

FY 2024–25 revenue provides a useful basis for comparing the overall size of diversified pharmaceutical businesses.

Indian Market Presence

Domestic pharmaceutical sales are particularly relevant when the objective is to identify companies that are important within India's medicine market.

International Operations

Many Indian pharmaceutical companies generate substantial revenue from the United States, Europe and other international markets.

Product Portfolio

The comparison considers the breadth of businesses covering generics, branded formulations, APIs, specialty medicines, biosimilars and other pharmaceutical products.

Industry Relevance

Companies with substantial manufacturing, research, distribution and export operations have greater significance within India's pharmaceutical ecosystem.

1. Sun Pharmaceutical Industries

Sun Pharmaceutical Industries is the largest company in this editorial ranking and one of India's most prominent pharmaceutical businesses.

The company operates across generic medicines, branded generics, specialty medicines, active pharmaceutical ingredients and other pharmaceutical products. It has a substantial international business and a significant presence in the Indian pharmaceutical market.

FY 2024–25 revenue for Sun Pharma was reported at approximately ₹52,041 crore in a comparison of leading Indian pharmaceutical companies. The same analysis placed Sun Pharma at the top among the companies covered.

Sun Pharma also remained the largest pharmaceutical company in India's domestic market. Its investor presentation based on AIOCD AWACS data showed an Indian formulation market share of 8.3% for the twelve months ended September 2025.

Key Strengths

• Very large pharmaceutical business
• Strong Indian market presence
• Significant international operations
• Specialty and generic medicines
• Broad product portfolio

Why It Matters

Sun Pharma's scale, domestic market position and international presence make it one of the most important companies in India's pharmaceutical industry.

2. Dr. Reddy's Laboratories

Dr. Reddy's Laboratories is a major Indian pharmaceutical company with operations spanning generics, APIs, biosimilars and innovative products.

The company has a substantial international presence, particularly in markets such as the United States, as well as a significant Indian business.

For FY 2024–25, Dr. Reddy's reported revenue of approximately ₹31,632 crore in the industry comparison used for this article, placing it second among the leading companies in that comparison.

Research and development is another important part of the company's business strategy. The company invests in product development and complex generics aimed at regulated international markets.

Key Strengths

• Strong international business
• Generics and APIs
• Biosimilar capabilities
• Research and development
• Presence in regulated markets

Why It Matters

Dr. Reddy's is particularly important to India's pharmaceutical export ecosystem and demonstrates the global reach of Indian drug manufacturers.

3. Aurobindo Pharma

Aurobindo Pharma is a major Indian pharmaceutical manufacturer with a substantial international business.

Its operations include generic formulations, active pharmaceutical ingredients and specialty pharmaceutical products. The company serves several international markets and has manufacturing facilities supporting its global operations.

In FY 2024–25, Aurobindo Pharma recorded revenue of approximately ₹31,378 crore in the industry comparison, placing it among India's largest pharmaceutical companies.

The company's strength in vertically integrated pharmaceutical manufacturing has been an important part of its business model.

Key Strengths

• Large generic-drug business
• API manufacturing
• International market presence
• Broad manufacturing infrastructure
• Strong export orientation

Why It Matters

Aurobindo Pharma is a major contributor to India's position as a global supplier of generic medicines and pharmaceutical ingredients.

4. Cipla

Cipla is one of India's best-known pharmaceutical companies and has a particularly strong position in the domestic market.

The company operates across prescription medicines, respiratory products, generics and other pharmaceutical categories. Its portfolio covers several therapeutic areas and its products are sold across multiple international markets.

Cipla reported sales of approximately ₹27,145 crore in FY 2024–25 in the industry comparison used here.

The company is also one of the largest pharmaceutical players in India's domestic market. AIOCD AWACS data cited in Sun Pharma's investor presentation showed Cipla with 5.6% of the Indian formulation market for the twelve months ended December 2025.

Key Strengths

• Strong Indian pharmaceutical presence
• Respiratory medicine expertise
• Large branded-generics portfolio
• International business
• Established pharmaceutical brand

Why It Matters

Cipla is important both as a domestic pharmaceutical company and as an international supplier of generic and specialty medicines.

5. Zydus Lifesciences

Zydus Lifesciences is a diversified Indian pharmaceutical and healthcare company with operations spanning generics, branded formulations, specialty medicines, APIs, vaccines and other healthcare products.

The company has developed a substantial international business while maintaining a significant presence in India.

Zydus recorded revenue of approximately ₹22,574 crore in FY 2024–25 in the industry comparison, moving into fifth position in that particular ranking.

The company's broad portfolio and investment in research have contributed to its growing position in the pharmaceutical sector.

Key Strengths

• Diverse pharmaceutical portfolio
• Generics and specialty products
• Vaccine capabilities
• Research and development
• Domestic and international operations

Why It Matters

Zydus is one of India's major pharmaceutical businesses and has become increasingly significant in specialty and research-oriented healthcare.

6. Lupin

Lupin is a major Indian pharmaceutical company with a strong presence in India and international markets.

Its portfolio includes generic medicines, branded formulations, specialty products and APIs.

Lupin reported FY 2024–25 sales of approximately ₹22,192 crore in the industry comparison. The company's own FY 2025 results also highlighted strong North American sales and Indian formulation sales.

According to the company's FY 2025 results, India formulation sales reached ₹7,577.3 crore, while North America sales were approximately ₹8,395 crore.

Key Strengths

• Strong generic medicines business
• Major US presence
• Significant Indian business
• Specialty pharmaceutical capabilities
• Established manufacturing network

Why It Matters

Lupin demonstrates the international scale achieved by Indian pharmaceutical companies, particularly in the US generic-drug market.

7. Biocon

Biocon is a major Indian biopharmaceutical company with a business model that differs from traditional generic-drug manufacturers.

The company has substantial expertise in biologics, biosimilars and other complex pharmaceutical products. Its operations also extend through Biocon Biologics and related businesses.

Biocon recorded revenue of approximately ₹15,052 crore in FY 2024–25 in the industry comparison.

The company is particularly relevant to India's biotechnology and biopharmaceutical sectors because of its focus on complex biological medicines.

Key Strengths

• Biologics expertise
• Biosimilars
• Biopharmaceutical research
• International operations
• Biotechnology capabilities

Why It Matters

Biocon represents the shift in India's pharmaceutical industry from conventional generic medicines toward more complex biological and specialty therapies.

8. Glenmark Pharmaceuticals

Glenmark Pharmaceuticals is an Indian pharmaceutical company with businesses across branded generics, specialty medicines and research-driven pharmaceutical products.

The company has a presence in India and international markets and has historically invested in research and development.

Glenmark recorded revenue of approximately ₹13,146 crore in FY 2024–25 in the industry comparison.

Its positioning is particularly relevant to the specialty pharmaceutical segment.

Key Strengths

• Specialty pharmaceuticals
• Branded generics
• Research and development
• International operations
• Multiple therapeutic areas

Why It Matters

Glenmark is an important Indian pharmaceutical company for readers researching the intersection of branded generics, specialty medicines and pharmaceutical research.

9. Alkem Laboratories

Alkem Laboratories is a major Indian pharmaceutical company with a strong domestic presence.

The company operates across branded generics, generics, specialty products and other pharmaceutical categories. Its products cover a wide range of therapeutic areas.

Alkem recorded revenue of approximately ₹12,964 crore in FY 2024–25 in the industry comparison.

The company also has an international business, but its strong domestic pharmaceutical franchise remains an important part of its identity.

Key Strengths

• Strong Indian market presence
• Branded generics
• Wide therapeutic portfolio
• International operations
• Established pharmaceutical brands

Why It Matters

Alkem is particularly relevant when studying India's branded-generic pharmaceutical market and the importance of domestic prescription medicine businesses.

10. Mankind Pharma

Mankind Pharma has become one of India's prominent pharmaceutical and healthcare companies, particularly through its strong domestic branded-generic and consumer-healthcare businesses.

The company's portfolio covers prescription medicines as well as consumer healthcare products.

Mankind recorded revenue of approximately ₹12,207 crore in FY 2024–25 in the industry comparison used here.

The company has built significant recognition in the Indian market through its prescription and consumer brands.

Key Strengths

• Strong domestic presence
• Branded generics
• Consumer healthcare
• Wide distribution network
• Growing pharmaceutical business

Why It Matters

Mankind Pharma is an important example of the strength of India's domestic pharmaceutical and consumer-healthcare market.

Comparison of the Top 10 Pharma Companies

Company	FY 2024–25 Revenue in Industry Comparison	Major Strength
Sun Pharma	₹52,041 crore	Scale and diversified global business
Dr. Reddy's Laboratories	₹31,632 crore	International generics and pharmaceutical development
Aurobindo Pharma	₹31,378 crore	Generics and APIs
Cipla	₹27,145 crore	Domestic market and respiratory portfolio
Zydus Lifesciences	₹22,574 crore	Diversified pharmaceutical and specialty portfolio
Lupin	₹22,192 crore	US and Indian pharmaceutical businesses
Biocon	₹15,052 crore	Biologics and biosimilars
Glenmark Pharmaceuticals	₹13,146 crore	Specialty and research-driven medicines
Alkem Laboratories	₹12,964 crore	Domestic branded generics
Mankind Pharma	₹12,207 crore	Domestic pharmaceuticals and consumer healthcare

These figures are presented for comparison using the FY 2024–25 industry data referenced above. Revenue definitions can vary between consolidated, standalone and industry-reporting measures, so figures should not be mixed across different methodologies.

Indian Pharmaceutical Market

India's pharmaceutical market is large and diverse, with domestic demand supported by a growing population, increasing healthcare awareness, expansion of private healthcare and the continuing need for affordable medicines.

According to Pharma Trac data reported in January 2026, the Indian pharmaceutical market grew 8.1% in 2025 to approximately ₹2.4 lakh crore. The same market analysis identified Sun Pharma, Abbott and Cipla among the largest companies by Indian sales.

This distinction between Indian-market sales and total company revenue is important.

A company may rank highly by total revenue because of a large international business, while another may have a stronger position specifically within India's domestic pharmaceutical market.

Domestic Pharma Market vs Global Pharma Business

Indian pharmaceutical companies generally operate through a combination of domestic and international businesses.

Domestic Market

Domestic sales include medicines sold within India through hospitals, pharmacies, doctors, distributors and other healthcare channels.

International Market

Exports and overseas operations can include generic medicines, APIs, specialty products, biosimilars and other pharmaceutical products.

The United States is particularly important for many Indian pharmaceutical companies because of the size of its generic-drug market.

Companies such as Dr. Reddy's, Lupin, Aurobindo Pharma and Sun Pharma have significant international businesses.

Why Indian Pharma Companies Are Important Globally

India is widely recognised for its pharmaceutical manufacturing capabilities, particularly in generic medicines.

Indian companies supply medicines to many international markets and manufacture a substantial range of pharmaceutical products.

The industry is also moving into more complex areas such as:

• Biosimilars
• Specialty medicines
• Complex generics
• Injectable products
• Advanced drug-delivery systems
• Contract development and manufacturing
• Pharmaceutical research

This diversification is changing the profile of India's pharmaceutical sector.

Major Business Segments in the Indian Pharma Industry

Generic Medicines

Generic medicines remain one of the most important parts of India's pharmaceutical industry. They provide alternatives to branded medicines after applicable intellectual-property protections expire.

Branded Generics

Branded generics are particularly important in India's domestic prescription market, where companies market medicines under specific brand names.

APIs

Active pharmaceutical ingredients are the substances responsible for the therapeutic effect of medicines. India has a significant API manufacturing ecosystem.

Biosimilars

Biosimilars are biological medicines designed to be highly similar to already approved biological reference products. Companies such as Biocon have developed substantial expertise in this area.

Specialty Medicines

Specialty pharmaceuticals target specific diseases or complex treatment areas and can require greater research, manufacturing and regulatory expertise.

What Makes a Pharma Company Successful in India?

Several factors can influence the long-term performance of a pharmaceutical company.

Research and Development

Investment in R&D can help companies develop new products, complex generics and specialty medicines.

Manufacturing

Reliable manufacturing capacity and quality systems are critical in pharmaceutical production.

Regulatory Compliance

Pharmaceutical companies operate under extensive regulatory requirements in India and international markets.

Distribution

Strong distribution is particularly important in India's fragmented healthcare and pharmacy market.

International Approvals

For companies operating globally, approvals from regulators in markets such as the United States and Europe can be strategically important.

Product Portfolio

Companies with products across several therapeutic categories may have greater diversification than companies dependent on a small number of products.

Future of the Indian Pharmaceutical Industry

India's pharmaceutical sector is expected to remain an important part of the country's manufacturing and export economy.

Growth opportunities are emerging in specialty medicines, biosimilars, complex generics, contract research and manufacturing, active pharmaceutical ingredients and other advanced healthcare products.

At the same time, pharmaceutical companies face challenges including regulatory requirements, pricing pressure, intellectual-property issues, competition, raw-material costs and changing healthcare policies.

The companies that combine manufacturing quality, research capabilities, strong distribution and international regulatory expertise are likely to remain important participants in the industry.

Frequently Asked Questions

Which are the top 10 pharma companies in India?

Based on an editorial comparison using FY 2024–25 business scale and industry relevance, the top ten covered in this article are Sun Pharmaceutical Industries, Dr. Reddy's Laboratories, Aurobindo Pharma, Cipla, Zydus Lifesciences, Lupin, Biocon, Glenmark Pharmaceuticals, Alkem Laboratories and Mankind Pharma.

Which is the largest pharma company in India?

Sun Pharmaceutical Industries is the largest company in this comparison by overall business scale. It also held the largest share of the Indian formulation market among companies shown in recent AIOCD AWACS data.

Which Indian pharma companies have a strong international presence?

Several major Indian pharmaceutical companies have substantial international businesses, including Sun Pharma, Dr. Reddy's Laboratories, Aurobindo Pharma, Cipla, Lupin and Zydus Lifesciences.

Which pharma company has a strong presence in the Indian market?

Sun Pharma is the largest pharmaceutical company in India by formulation market share according to the AIOCD AWACS data cited in its investor presentations. Cipla, Mankind Pharma, Alkem, Zydus, Torrent, Lupin and other companies also have significant domestic businesses.

Is Biocon a pharmaceutical company?

Yes. Biocon is an Indian biopharmaceutical company with major capabilities in biologics and biosimilars, in addition to other pharmaceutical businesses.

What is the difference between a pharma company and an API company?

A pharmaceutical company may manufacture finished medicines, while an API-focused company primarily produces active pharmaceutical ingredients used to manufacture medicines. Many large Indian pharmaceutical companies operate in both areas.

Which factors should be considered when ranking pharma companies?

Revenue, domestic pharmaceutical sales, international presence, manufacturing capacity, product portfolio, R&D capabilities and industry relevance can all be used. The ranking can change depending on which metric is selected.

Is this an official ranking of India's pharma companies?

No. This is an editorial ranking prepared for general company and industry research. Official rankings may use different criteria and should be consulted when a specific regulatory or market measure is required.

Conclusion

India's pharmaceutical industry includes some of the country's largest manufacturing and export-oriented businesses. Sun Pharma, Dr. Reddy's Laboratories, Aurobindo Pharma, Cipla, Zydus Lifesciences, Lupin, Biocon, Glenmark Pharmaceuticals, Alkem Laboratories and Mankind Pharma are among the major companies that illustrate the breadth of India's pharmaceutical sector.

Sun Pharma leads this comparison by overall business scale, while Dr. Reddy's and Aurobindo have significant international operations. Cipla and Alkem have strong domestic franchises, Zydus has a broad pharmaceutical portfolio, Lupin has substantial US and Indian businesses, Biocon has specialised expertise in biopharmaceuticals, Glenmark has a specialty and research-oriented profile, and Mankind Pharma has developed a strong domestic branded-generic and consumer-healthcare business.

The Indian pharmaceutical industry is also moving beyond traditional generic medicines toward specialty products, biosimilars, complex formulations and research-driven healthcare. This combination of domestic demand, manufacturing capabilities and international exports makes pharma one of India's most important industrial sectors.